Cargando…

COVID-19 and AKI: Where Do We Stand?

Detalles Bibliográficos
Autor principal:	Palevsky, Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Nephrology 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259685/ https://www.ncbi.nlm.nih.gov/pubmed/33637516 http://dx.doi.org/10.1681/ASN.2020121768

Ejemplares similares

The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
por: Franzin, Rossana, et al.
Publicado: (2020)

COVID-19 and liver injury: where do we stand?
por: Papadopoulos, Nikolaos, et al.
Publicado: (2020)

Chloroquine and COVID-19, where do we stand?()
por: Lecuit, M.
Publicado: (2020)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

COVID-19 in Children: Where do we Stand?
por: Nikolopoulou, Georgia B., et al.
Publicado: (2022)

Where Do We Stand?
Publicado: (1891)

Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012)

Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)

Schistosomiasis vaccines: where do we stand?
por: Tebeje, Biniam Mathewos, et al.
Publicado: (2016)

Vaccine for Diabetes—Where Do We Stand?
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2022)

Genetics of Keratoconus: Where Do We Stand?
por: Abu-Amero, Khaled K., et al.
Publicado: (2014)

Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?
por: Daoud, Ahmed, et al.
Publicado: (2021)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Cricoid pressure: Where do we stand?
por: Bhatia, Nidhi, et al.
Publicado: (2014)

Bevacizumab in Glaucoma: Where do We Stand?
por: Khanna, Anjani
Publicado: (2012)

Telemedicine in India: Where do we stand?
por: Chellaiyan, Vinoth G., et al.
Publicado: (2019)

Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
por: Sagris, Marios, et al.
Publicado: (2022)

Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
por: Esposito, Renata, et al.
Publicado: (2022)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Coronavirus (COVID-19) and Stress: Where Do We Stand in This Journey and Where Are We Leading to!
por: Avinash, Bhagyalakshmi, et al.
Publicado: (2022)

COVID-19 Vaccine in Children: Where Do We Stand?
por: Kumar, Jogender, et al.
Publicado: (2021)

Vaccines for COVID-19: Where do we stand in 2021?
por: Sharma, Ketaki, et al.
Publicado: (2021)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
por: Horváth, Balázs, et al.
Publicado: (2022)

Covid-19 and perioperative mortality; where do we stand?
por: Shakiba, Behnam, et al.
Publicado: (2020)

Fluvoxamine for outpatients with COVID-19: where do we stand?
por: Berwanger, Otavio
Publicado: (2022)

Managing adult Fontan patients: where do we stand?
por: Clift, Paul, et al.
Publicado: (2016)

Current Melanoma Treatments: Where Do We Stand?
por: Moreira, Alvaro, et al.
Publicado: (2021)

Neurogenic Erectile Dysfunction. Where Do We Stand?
por: Thomas, Charalampos, et al.
Publicado: (2021)

Tumor-Associated Microbiome: Where Do We Stand?
por: Oliva, Marc, et al.
Publicado: (2021)

Nanocarriers for Skin Applications: Where Do We Stand?
por: Tiwari, Neha, et al.
Publicado: (2021)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Biliary atresia: Where do we stand now?
por: Govindarajan, Krishna Kumar
Publicado: (2016)

Targeting Apoptosis in AML: Where Do We Stand?
por: Krawiec, Kinga, et al.
Publicado: (2022)

The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?
por: Werner, Rudolf A., et al.
Publicado: (2018)

Selenium, Stroke, and Infection: A Threefold Relationship; Where Do We Stand and Where Do We Go?
por: Liampas, Andreas, et al.
Publicado: (2023)

Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
por: Radzina, Maija, et al.
Publicado: (2023)

Treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Where Do We Stand? Where Do We Go?
por: Eichenauer, Dennis A., et al.
Publicado: (2023)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
por: Banz-Jansen, Constanze, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i0nla9gerdke5smn39098s4d5a